Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Cerilliant
Healthtrust
Chubb
Teva
Chinese Patent Office
Medtronic
Boehringer Ingelheim
Express Scripts

Generated: June 20, 2018

DrugPatentWatch Database Preview

HEAVY SOLUTION NUPERCAINE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Heavy Solution Nupercaine, and when can generic versions of Heavy Solution Nupercaine launch?

Heavy Solution Nupercaine is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in HEAVY SOLUTION NUPERCAINE is dibucaine hydrochloride. Additional details are available on the dibucaine hydrochloride profile page.
Summary for HEAVY SOLUTION NUPERCAINE
Drug patent expirations by year for HEAVY SOLUTION NUPERCAINE
Medical Subject Heading (MeSH) Categories for HEAVY SOLUTION NUPERCAINE
Synonyms for HEAVY SOLUTION NUPERCAINE
.alpha.-Butyloxycinchoninic acid diethylethylenediamide
012D735
2- paragraph sign inverted exclamation markNo>>u-N-(2- paragraph signthornOO degrees +/-OO>>u)-4-a-sso(1/4)xo pound degrees . NIEaNI
2-Butoxy-N-(.beta.-diethylaminoethyl)cinchoninamide
2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide
2-butoxy-N-(2-(diethylamino)ethyl)quinoline-4-carboxamide
2-Butoxy-N-(2-(diethylamino)ethyl)quinoline-4-carboxamide hydrochloride
2-Butoxy-N-(2-diethylaminoethyl)-4-quinolinecarboxamide hydrochloride
2-butoxy-N-(2-diethylaminoethyl)quinoline-4-carboxamide
2-butoxy-N-(2-diethylaminoethyl)quinoline-4-carboxamide hydrochloride
2-butoxy-N-(alpha-diethylaminoethyl)cinchoninamide
2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide
2-Butoxy-N-(beta.-diethylaminoethyl)cinchoninamide
2-Butoxy-N-[2-(diethylamino)-ethyl]-4-quinoline carboxamide hydrochloride
2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide
2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide #
2-butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide hydrochloride
2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide monohydrochloride
2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide monohydrochloride; 2-Butoxy-N-(2-diethylaminoethyl)cinchoninamide hydrochloride
2-butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide;hydrochloride
2-Butoxy-N-[2-(diethylamino)ethyl]cinchoninamide
2-butoxy-N-[2-(diethylamino)ethyl]cinchoninamide;hydrochloride
2-butoxy-N-[2-(diethylamino)ethyl]quinoline-4-carboxamide
2-butoxy-N-[2-(diethylamino)ethyl]quinoline-4-carboxamide hydrochloride
2-butoxy-N-[2-(diethylamino)ethyl]quinoline-4-carboxamide;hydrochloride
2-butoxy-N-[2-(diethylamino)ethyl]quinoline-4-carboximidic acid
2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide
2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide
2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide
4-22-00-02284 (Beilstein Handbook Reference)
4-Quinolinecarboxamide, 2-butoxy-N-(2-(diethylamino)ethyl)-
4-Quinolinecarboxamide, 2-butoxy-N-[2-(diethylamino)ethyl]-
4-quinolinecarboxamide, 2-butoxy-N-[2-(diethylamino)ethyl]-, hydrochloride (1:1)
4-Quinolinecarboxamide,2-butoxy-N-[2-(diethylamino)ethyl]-
61-12-1
85-79-0
A833051
AB00053453
AB00053453_24
AB00053453_25
AB0012106
AB1004834
AC-15501
AC-2093
AC1L1F05
AC1LAWAM
ACT04722
AJ-26713
AK161941
AK326166
AKOS015897110
AKOS015897111
alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine
alpha-Butyloxycinchoninic acid diethylethylenediamide
AN-14281
AN-23641
API0002315
AS-12541
AS-17426
AX8042063
BAS 00401270
BCP0726000008
BCP9000604
BDBM48532
Benzolin (local anesthetic)
BPBio1_000321
BRD-K99121711-001-03-5
BRD-K99121711-003-02-3
BRN 0275489
BSPBio_000291
BSPBio_002167
Butoxycinchoninic acid diethylethylenediamide hydrochloride
C 3225
C-20421
C07879
C20H29N3O2
C20H29N3O2.HCl
CAS-85-79-0
CC-26504
CCG-220076
CCG-40219
CHEBI:247956
CHEBI:59735
CHEMBL1086
CHEMBL1200612
cid_521951
Cincain
Cincaine chloride
Cincaine hydrochloride
Cincainum
Cinchocaine
Cinchocaine (INN)
Cinchocaine HCL
Cinchocaine hydrochloride
Cinchocaine Hydrochloride 1.0 mg/ml in Methanol (as free base)
Cinchocaine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Cinchocaine(Dibucaine)
Cinchocaine/Dibucaine
Cinchocainium chloride
Cinchocainum
Cinchocainum [INN-Latin]
Cinchokain hydrochlorid
Cinchokain hydrochlorid [Czech]
Cinchoninamide, 2-butoxy-N-(2-(diethylamino)ethyl)-
CINCHONINAMIDE, 2-BUTOXY-N-(2-(DIETHYLAMINO)ETHYL)-, MONOHYDROCHLORIDE
Cinchoninamide, 2-butoxy-N-[2-(diethylamino)ethyl]-
Cincocaina
Cincocaina [DCIT]
Cincocainio
Cincocainio [INN-Spanish]
CS-2656
CS-2657
CTK8F9135
CTK8F9136
D00733
D02220
D0P5GE
DB00527
Dermacaine
Dibucain
dibucaine
Dibucaine (Cinchocaine) HCl
Dibucaine (hydrochloride)
Dibucaine (USP)
Dibucaine [USP]
Dibucaine Base
Dibucaine HCl
Dibucaine hydrochloride
Dibucaine hydrochloride (JP17/USP)
Dibucaine hydrochloride [USP:JAN]
Dibucaine hydrochloride, analytical standard, >=99%
Dibucaine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Dibucainum
DivK1c_000332
DR001705
DSSTox_CID_25271
DSSTox_GSID_45271
DSSTox_RID_80780
DTXSID3045271
EBD27501
EINECS 200-498-1
EINECS 201-632-1
FT-0603086
FT-0666517
GTPL7159
HE397647
HMS1568O13
HMS1920E14
HMS2095O13
HMS2233F03
HMS3370I12
HSDB 3312
HY-B0552
HY-B0552A
I08-0059
I08-0084
IDI1_000332
InChI=1/C20H29N3O2/c1-4-7-14-25-19-15-17(16-10-8-9-11-18(16)22-19)20(24)21-12-13-23(5-2)6-3/h8-11,15H,4-7,12-14H2,1-3H3,(H,21,24
KBio1_000332
KBio2_001408
KBio2_003976
KBio2_006544
KBio3_001387
KBioGR_001049
KBioSS_001408
KS-00000F9B
KS-00000L64
L6JW2TJG99
LS-53768
MCULE-2036117305
MCULE-4397469465
MFCD00012735
MFCD00047595
MLS000028425
MLS000028429
MLS001076275
MLS001148085
MolPort-001-783-628
MolPort-003-666-160
N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide
N-[2-(Diethylamino)ethyl]-2-butoxycinchoninamide
N-[2-(diethylamino)ethyl](2-butoxy(4-quinolyl))carboxamide
N-[2-(diethylamino)ethyl](2-butoxy(4-quinolyl))carboxamide, chloride
NCGC00016338-01
NCGC00016338-02
NCGC00016338-03
NCGC00016338-04
NCGC00016338-05
NCGC00016338-06
NCGC00016338-07
NCGC00016338-10
NCGC00094647-01
NCGC00094647-02
NCGC00094647-03
NINDS_000332
NSC 159055
NSC-159055
NSC-756724
NSC159055
NSC756724
Nupercainal
Nupercainal (TN)
Nupercainal (VAN)
Nupercaine
Nupercaine (TN)
Nupercaine hydrochloride
Nupercaine hydrochloride (TN)
Opera_ID_1096
Opera_ID_192
Percain
Percaine
Percamin (TN)
Percamin S
Percamine
Pharmakon1600-01500236
Prestwick_164
Prestwick0_000076
Prestwick1_000076
Prestwick2_000076
Prestwick3_000076
PubChem20328
PUFQVTATUTYEAL-UHFFFAOYSA-N
Q-100001
Q-100863
QUINOLINE,2-BUTOXY,4-CARBOXY,(N-TRIETHYLAMINO) AMIDE CINCHOCAIN
QUINOLINE,2-BUTOXY,4-CARBOXY,(N-TRIETHYLAMINO) AMIDE CINCHOCAIN
s4038
SBI-0051340.P003
SC-24437
SC-26885
SCHEMBL31303
SCHEMBL34473
SMR000058369
SMR000058391
Sovcain
Sovcaine
Sovcaine (TN)
Sovcainum
SPBio_001121
SPBio_002212
Spectrum_000928
SPECTRUM1500236
Spectrum2_001001
Spectrum3_000384
Spectrum4_000505
Spectrum5_000865
ST24046324
ST50319978
ST51037211
STL483757
Tox21_110381
Tox21_110381_1
UNII-L6JW2TJG99
UNII-Z97702A5DG
WLN: T66 BNJ CO4 EVM2N2&2
Z97702A5DG
ZINC1530939

US Patents and Regulatory Information for HEAVY SOLUTION NUPERCAINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis HEAVY SOLUTION NUPERCAINE dibucaine hydrochloride INJECTABLE;INJECTION 006203-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Merck
Mallinckrodt
Fuji
Deloitte
Harvard Business School
Accenture
Cantor Fitzgerald
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.